Evidence map›Paper›PMID 41489763›Full record

ReviewRadiological physics and technology2026

Correction and utilization of the washout effect in range-verification PET for particle therapy.

Chie Toramatsu, Iwao Kanno, Taiga Yamaya

Abstract readReview
In one paragraph

Review in Radiological physics and technology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Chie ToramatsuNational Institutes for Quantum Science and Technology, 4‑9‑1, Anagawa, Inage‑ku, Chiba, 263‑8555, Japan. toramatsu.chie@qst.go.jp.ORCID http://orcid.org/0000-0003-2334-1986
Iwao KannoNational Institutes for Quantum Science and Technology, 4‑9‑1, Anagawa, Inage‑ku, Chiba, 263‑8555, Japan.
Taiga YamayaNational Institutes for Quantum Science and Technology, 4‑9‑1, Anagawa, Inage‑ku, Chiba, 263‑8555, Japan.

Funding

Japan Society for the Promotion of Science London 23KK0206Japan Society for the Promotion of Science London 24K10826Nakatani Foundation for Advancement of Measuring Technologies in Biomedical Engineering Nakatani Foundation for Advancement of Measuring Technologies in Biomedical Engineering
6 · The paper itself

Abstract

In charged particle therapy, it is essential to verify the irradiation beam range. Thus, using positron (β+)-emitting nuclides which are produced in irradiated tissue, positron emission tomography (PET) has been studied, and clinically applied for in vivo range verification in particle therapy. However, a correction method for the biological washout effect is one of the fundamental issues for quantitative verification of the beam range; the irradiation-induced β+-emitting nuclides are affected by the pathophysiological environment such as blood perfusion. Since the biological washout effect is a tissue-specific phenomenon, extensive basic and clinical research has been conducted for modeling its kinetic process. Although considered as an undesirable factor in PET-based range validation, on the other hand, the biological washout effect may provide unique insights into the vascular status of a tumor and potentially support evaluation of the cancer pathophysiology. Consequently, this review provides a comprehensive outline of studies of the biological washout effect in particle therapy, focusing on both its correction and potential beneficial utilization.

Indexed as

Image Processing, Computer-AssistedPositron-Emission TomographyAnimalsHumansNeoplasmsBlood perfusionKinetic analysisParticle therapyPETTumorWashout

Identifiers

PMID41489763
PMCPMC12950064

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.